ArticleWorld journal of urology2022
T2 mapping for the characterization of prostate lesions.
Article in World journal of urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- From signal-intensity ratio to decision-grade triage in prostate MRI.Abdominal radiology (New York) · 2026Article
- Optimal Selection of the Effective Echo Time (TEJournal of magnetic resonance imaging : JMRI · 2026Article
- Stratified Analysis of Patients Within the PSA Gray Zone (4-10 ng/mL) and Its Clinical Application Value: Development of a Predictive Model for Clinically Significant Prostate Cancer Using Quantitative Indicators of PSA, ADC, and Relative T2 Value.Diagnostics (Basel, Switzerland) · 2026Article
- Value of T2-weighted signal intensity index in reducing unnecessary biopsies for peripheral zone lesions PI-RADS (v2.1) ≥ 3.Abdominal radiology (New York) · 2026Article
- Quantitative synthetic MRI improves peripheral zone prostate cancer detection beyond PI-RADS v2.1.International urology and nephrology · 2026Article
- T2 relaxation time of prostate measured at 5T: preliminary results in healthy adults.BMC medical imaging · 2026Article
- Development and validation of a risk prediction model for prostate cancer integrating quantitative MRI and clinical data.Frontiers in oncology · 2026Article
- An explanation for why tissues with T2 of around 70 milliseconds always measure low MRI apparent diffusion coefficient (ADC).Quantitative imaging in medicine and surgery · 2025Article
- Retrospectively Quantified T2 Improves Detection of Clinically Significant Peripheral Zone Prostate Cancer.Cancers · 2025Article
- Utility of quantitative measurement of TScientific reports · 2024Article
- Value of MRI - T2 Mapping to Differentiate Clinically Significant Prostate Cancer.Journal of imaging informatics in medicine · 2024Article
- DeepEMC-TMagnetic resonance in medicine · 2024Article
- Improved quantitative parameter estimation for prostate TMagma (New York, N.Y.) · 2024Article
- Predicting the status of lymphovascular space invasion using quantitative parameters from synthetic MRI in cervical squamous cell carcinoma without lymphatic metastasis.Frontiers in oncology · 2024Article
- A tri-phasic relationship between T2 relaxation time and magnetic resonance imaging (MRI)-derived apparent diffusion coefficient (ADC).Quantitative imaging in medicine and surgery · 2023Article
- The relevance of T2 relaxation time in interpreting MRI apparent diffusion coefficient (ADC) map for musculoskeletal structures.Quantitative imaging in medicine and surgery · 2023Article
- Study of T2 mapping in quantifying and discriminating uterine lesions under different magnetic field strengths: 1.5 T vs. 3.0 T.BMC medical imaging · 2023Article
- Retrospective T2 quantification from conventional weighted MRI of the prostate based on deep learning.Frontiers in radiology · 2023Article
- State-of-the-art Prostate Imaging.Sisli Etfal Hastanesi tip bulteni · 2023Review
- Imaging in translational cancer research.Cancer biology & medicine · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePurpose of this study is to evaluate the diagnostic accuracy of quantitative T2/ADC values in differentiating between PCa and lesions showing non-specific inflammatory infiltrates and atrophy, features of chronic prostatitis, as the most common histologically proven differential diagnosis.
methodsIn this retrospective, single-center cohort study, we analyzed 55 patients suspected of PCa, who underwent mpMRI (3T) including quantitative T2 maps before robot-assisted mpMRI-TRUS fusion prostate biopsy. All prostate lesions were scored according to PI-RADS v2.1. Regions of interest (ROIs) were annotated in focal lesions and normal prostate tissue. Quantitative mpMRI values from T2 mapping and ADC were compared using two-tailed t tests. Receiver operating characteristic curves (ROCs) and cutoff were calculated to differentiate between PCa and chronic prostatitis.
resultsFocal lesions showed significantly lower ADC and T2 mapping values than normal prostate tissue (p < 0.001). PCa showed significantly lower ADC and T2 values than chronic prostatitis (p < 0.001). ROC analysis revealed areas under the receiver operating characteristic curves (AUCs) of 0.85 (95% CI 0.74-0.97) for quantitative ADC values and 0.84 (95% CI 0.73-0.96) for T2 mapping. A significant correlation between ADC and T2 values was observed (r = 0.70; p < 0.001).
conclusionT2 mapping showed high diagnostic accuracy for differentiating between PCa and chronic prostatitis, comparable to the performance of ADC values.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.